General Information of Drug Off-Target (DOT) (ID: OTDWEEBQ)

DOT Name LHFPL tetraspan subfamily member 2 protein (LHFPL2)
Synonyms Lipoma HMGIC fusion partner-like 2 protein
Gene Name LHFPL2
Related Disease
Cardiovascular disease ( )
IgA nephropathy ( )
Brain neoplasm ( )
Parkinson disease ( )
UniProt ID
LHPL2_HUMAN
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
Pfam ID
PF10242
Sequence
MCHVIVTCRSMLWTLLSIVVAFAELIAFMSADWLIGKARSRGGVEPAGPGGGSPEPYHPT
LGIYARCIRNPGVQHFQRDTLCGPYAESFGEIASGFWQATAIFLAVGIFILCMVALVSVF
TMCVQSIMKKSIFNVCGLLQGIAGLFLILGLILYPAGWGCQKAIDYCGHYASAYKPGDCS
LGWAFYTAIGGTVLTFICAVFSAQAEIATSSDKVQEEIEEGKNLICLL
Function Plays a role in female and male fertility. Involved in distal reproductive tract development.
Tissue Specificity Expressed in all tissues and cell lines examined except brain and peripheral blood leukocytes.
Reactome Pathway
Platelet degranulation (R-HSA-114608 )

Molecular Interaction Atlas (MIA) of This DOT

4 Disease(s) Related to This DOT
Disease Name Disease ID Evidence Level Mode of Inheritance REF
Cardiovascular disease DIS2IQDX Strong Genetic Variation [1]
IgA nephropathy DISZ8MTK Strong Biomarker [2]
Brain neoplasm DISY3EKS Limited Altered Expression [3]
Parkinson disease DISQVHKL Limited Genetic Variation [3]
------------------------------------------------------------------------------------
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DOT
11 Drug(s) Affected the Gene/Protein Processing of This DOT
Drug Name Drug ID Highest Status Interaction REF
Valproate DMCFE9I Approved Valproate affects the expression of LHFPL tetraspan subfamily member 2 protein (LHFPL2). [4]
Ciclosporin DMAZJFX Approved Ciclosporin increases the expression of LHFPL tetraspan subfamily member 2 protein (LHFPL2). [5]
Tretinoin DM49DUI Approved Tretinoin increases the expression of LHFPL tetraspan subfamily member 2 protein (LHFPL2). [6]
Acetaminophen DMUIE76 Approved Acetaminophen increases the expression of LHFPL tetraspan subfamily member 2 protein (LHFPL2). [7]
Calcitriol DM8ZVJ7 Approved Calcitriol increases the expression of LHFPL tetraspan subfamily member 2 protein (LHFPL2). [8]
Testosterone DM7HUNW Approved Testosterone increases the expression of LHFPL tetraspan subfamily member 2 protein (LHFPL2). [8]
Triclosan DMZUR4N Approved Triclosan decreases the expression of LHFPL tetraspan subfamily member 2 protein (LHFPL2). [9]
Phenobarbital DMXZOCG Approved Phenobarbital affects the expression of LHFPL tetraspan subfamily member 2 protein (LHFPL2). [10]
Piroxicam DMTK234 Approved Piroxicam increases the expression of LHFPL tetraspan subfamily member 2 protein (LHFPL2). [11]
Benzo(a)pyrene DMN7J43 Phase 1 Benzo(a)pyrene decreases the expression of LHFPL tetraspan subfamily member 2 protein (LHFPL2). [12]
THAPSIGARGIN DMDMQIE Preclinical THAPSIGARGIN decreases the expression of LHFPL tetraspan subfamily member 2 protein (LHFPL2). [13]
------------------------------------------------------------------------------------
⏷ Show the Full List of 11 Drug(s)
1 Drug(s) Affected the Post-Translational Modifications of This DOT
Drug Name Drug ID Highest Status Interaction REF
Bisphenol A DM2ZLD7 Investigative Bisphenol A increases the methylation of LHFPL tetraspan subfamily member 2 protein (LHFPL2). [14]
------------------------------------------------------------------------------------

References

1 Leveraging Polygenic Functional Enrichment to Improve GWAS Power.Am J Hum Genet. 2019 Jan 3;104(1):65-75. doi: 10.1016/j.ajhg.2018.11.008. Epub 2018 Dec 27.
2 The molecular phenotype of endocapillary proliferation: novel therapeutic targets for IgA nephropathy.PLoS One. 2014 Aug 18;9(8):e103413. doi: 10.1371/journal.pone.0103413. eCollection 2014.
3 Identification of genetic modifiers of age-at-onset for familial Parkinson's disease.Hum Mol Genet. 2016 Sep 1;25(17):3849-3862. doi: 10.1093/hmg/ddw206. Epub 2016 Jul 11.
4 Gene Expression Regulation and Pathway Analysis After Valproic Acid and Carbamazepine Exposure in a Human Embryonic Stem Cell-Based Neurodevelopmental Toxicity Assay. Toxicol Sci. 2015 Aug;146(2):311-20. doi: 10.1093/toxsci/kfv094. Epub 2015 May 15.
5 Comparison of HepG2 and HepaRG by whole-genome gene expression analysis for the purpose of chemical hazard identification. Toxicol Sci. 2010 May;115(1):66-79.
6 Phenotypic characterization of retinoic acid differentiated SH-SY5Y cells by transcriptional profiling. PLoS One. 2013 May 28;8(5):e63862.
7 Multiple microRNAs function as self-protective modules in acetaminophen-induced hepatotoxicity in humans. Arch Toxicol. 2018 Feb;92(2):845-858.
8 Effects of 1alpha,25 dihydroxyvitamin D3 and testosterone on miRNA and mRNA expression in LNCaP cells. Mol Cancer. 2011 May 18;10:58.
9 Transcriptome and DNA methylome dynamics during triclosan-induced cardiomyocyte differentiation toxicity. Stem Cells Int. 2018 Oct 29;2018:8608327.
10 Reproducible chemical-induced changes in gene expression profiles in human hepatoma HepaRG cells under various experimental conditions. Toxicol In Vitro. 2009 Apr;23(3):466-75. doi: 10.1016/j.tiv.2008.12.018. Epub 2008 Dec 30.
11 Apoptosis induced by piroxicam plus cisplatin combined treatment is triggered by p21 in mesothelioma. PLoS One. 2011;6(8):e23569.
12 Transcriptional signature of human macrophages exposed to the environmental contaminant benzo(a)pyrene. Toxicol Sci. 2010 Apr;114(2):247-59.
13 Endoplasmic reticulum stress impairs insulin signaling through mitochondrial damage in SH-SY5Y cells. Neurosignals. 2012;20(4):265-80.
14 DNA methylome-wide alterations associated with estrogen receptor-dependent effects of bisphenols in breast cancer. Clin Epigenetics. 2019 Oct 10;11(1):138. doi: 10.1186/s13148-019-0725-y.